Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, pathways, authors, ontology terms, etc. (e.g. eve, embryo, zen, allele)
  • Use OR to search for either of two terms (e.g. fly OR drosophila) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. dros* for partial matches or fly AND NOT embryo to exclude a term

Search results 4401 to 4500 out of 44733 for *

Category restricted to GOTerm (x)

<< First    < Previous  |  Next >    Last >>
0.016s

Categories

Category: GOTerm
« show all
Type Details Score
GO Term
GO:0002473 | non-professional antigen presenting cell antigen processing and presentation
Description: The process in which a non-professional antigen presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex. Non-professional antigen presenting cells include all cell types but dendritic cells, B cells, T cells, monocytes, macrophages, and neutrophils.
•
•
•
•
•
GO Term
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I
Description: The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
•
•
•
•
•
GO Term
GO:0002483 | antigen processing and presentation of endogenous peptide antigen
Description: The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell.
•
•
•
•
•
GO Term
GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib
Description: The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
•
•
•
•
•
GO Term
GO:0019883 | antigen processing and presentation of endogenous antigen
Description: The process in which an antigen-presenting cell expresses antigen (peptide or lipid) of endogenous origin on its cell surface in association with an MHC protein complex.
•
•
•
•
•
GO Term
GO:0002478 | antigen processing and presentation of exogenous peptide antigen
Description: The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell.
•
•
•
•
•
GO Term
GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib
Description: The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
•
•
•
•
•
GO Term
GO:0019884 | antigen processing and presentation of exogenous antigen
Description: The process in which an antigen-presenting cell expresses antigen (peptide or lipid) of exogenous origin on its cell surface in association with an MHC protein complex.
•
•
•
•
•
GO Term
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I
Description: The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules.
•
•
•
•
•
GO Term
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent
Description: The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.
•
•
•
•
•
GO Term
GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent
Description: The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.
•
•
•
•
•
GO Term
GO:0002481 | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent
Description: The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
•
•
•
•
•
GO Term
GO:0002482 | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-independent
Description: The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
•
•
•
•
•
GO Term
GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway
Description: The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via an ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER. Class I here refers to classical class I molecules.
•
•
•
•
•
GO Term
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent
Description: The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-dependent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following TAP-dependent transport from the cytosol. Class I here refers to classical class I molecules.
•
•
•
•
•
GO Term
GO:0002486 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent
Description: The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-independent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following transport from the cytosol via a TAP-independent pathway. Class I here refers to classical class I molecules.
•
•
•
•
•
GO Term
GO:0002487 | antigen processing and presentation of endogenous peptide antigen via MHC class I via endolysosomal pathway
Description: The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in an endolysosome. Class I here refers to classical class I molecules.
•
•
•
•
•
GO Term
GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway
Description: The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via an ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class Ib molecule in the ER. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
•
•
•
•
•
GO Term
GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent
Description: The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
•
•
•
•
•
GO Term
GO:0002490 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-independent
Description: The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
•
•
•
•
•
GO Term
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II
Description: The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
•
•
•
•
•
GO Term
GO:0002491 | antigen processing and presentation of endogenous peptide antigen via MHC class II
Description: The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
•
•
•
•
•
GO Term
GO:0002492 | peptide antigen assembly with MHC class Ib protein complex
Description: The binding of a peptide antigen to the antigen binding groove of an MHC class Ib protein complex. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
•
•
•
•
•
GO Term
GO:0002501 | peptide antigen assembly with MHC protein complex
Description: The binding of a peptide to the antigen binding groove of an MHC protein complex.
•
•
•
•
•
GO Term
GO:0002493 | lipid antigen assembly with MHC class Ib protein complex
Description: The binding of a lipid antigen to the antigen binding groove of an MHC class Ib protein complex. Class Ib here refers to non-classical class I molecules, such as those of the CD1 gene family.
•
•
•
•
•
GO Term
GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib
Description: The process in which an antigen-presenting cell expresses lipid antigen in association with an MHC class Ib protein complex on its cell surface, including lipid extraction, degradation, and transport steps for the lipid antigen both prior to and following assembly with the MHC protein complex. The lipid antigen may originate from an endogenous or exogenous source of lipid. Class Ib here refers to non-classical class I molecules, such as those of the CD1 family.
•
•
•
•
•
GO Term
GO:0065005 | protein-lipid complex assembly
Description: The aggregation, arrangement and bonding together of proteins and lipids to form a protein-lipid complex.
•
•
•
•
•
GO Term
GO:0071825 | protein-lipid complex subunit organization
Description: Any process in which macromolecules aggregate, disaggregate, or are modified, resulting in the formation, disassembly, or alteration of a protein-lipid complex.
•
•
•
•
•
GO Term
GO:0002494 | lipid antigen transport
Description: The directed movement of a lipid antigen into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0002497 | proteasomal proteolysis associated with antigen processing and presentation
Description: The hydrolysis of a peptide bond or bonds within a protein by the proteasome complex contributing to antigen processing and presentation.
•
•
•
•
•
GO Term
GO:0002498 | proteolysis within endoplasmic reticulum associated with antigen processing and presentation
Description: The hydrolysis of a peptide bond or bonds within a protein by ER resident proteases contributing to antigen processing and presentation.
•
•
•
•
•
GO Term
GO:0002499 | proteolysis within endosome associated with antigen processing and presentation
Description: The hydrolysis of a peptide bond or bonds within a protein by endosomal resident proteases contributing to antigen processing and presentation.
•
•
•
•
•
GO Term
GO:0002500 | proteolysis within lysosome associated with antigen processing and presentation
Description: The hydrolysis of a peptide bond or bonds within a protein by lysosomal resident proteases contributing to antigen processing and presentation.
•
•
•
•
•
GO Term
GO:0002502 | peptide antigen assembly with MHC class I protein complex
Description: The binding of a peptide to the antigen binding groove of an MHC class I protein complex. Class I here refers to classical class I molecules.
•
•
•
•
•
GO Term
GO:0002503 | peptide antigen assembly with MHC class II protein complex
Description: The binding of a peptide to the antigen binding groove of an MHC class II protein complex.
•
•
•
•
•
GO Term
GO:0002505 | antigen processing and presentation of polysaccharide antigen via MHC class II
Description: The process in which an antigen-presenting cell expresses a polysaccharide antigen on its cell surface in association with an MHC class II protein complex.
•
•
•
•
•
GO Term
GO:0002509 | central tolerance induction to self antigen
Description: Tolerance induction in the central lymphoid organs directed at self antigens.
•
•
•
•
•
GO Term
GO:0002511 | central B cell receptor editing
Description: Receptor editing occurring in B cells in the bone marrow.
•
•
•
•
•
GO Term
GO:0002512 | central T cell tolerance induction
Description: Tolerance induction of T cells in the thymus.
•
•
•
•
•
GO Term
GO:0002518 | lymphocyte chemotaxis across high endothelial venule
Description: The movement of a lymphocyte to cross a high endothelial venule in response to an external stimulus.
•
•
•
•
•
GO Term
GO:0002519 | natural killer cell tolerance induction
Description: Tolerance induction of natural killer cells.
•
•
•
•
•
GO Term
GO:0002525 | acute inflammatory response to non-antigenic stimulus
Description: An acute inflammatory response to non-antigenic stimuli such as heat or physical trauma.
•
•
•
•
•
GO Term
GO:0002527 | vasodilation involved in acute inflammatory response
Description: An increase in the internal diameter of blood vessels, especially arterioles or capillaries, usually resulting in a decrease in blood pressure contributing to an acute inflammatory response.
•
•
•
•
•
GO Term
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response
Description: Any process that modulates the extent to which blood vessels can be pervaded by fluid contributing to an acute inflammatory response.
•
•
•
•
•
GO Term
GO:0002529 | regulation of plasma kallikrein-kinin cascade
Description: Any process that modulates the frequency, rate, or extent of the plasma kallikrein-kinin cascade.
•
•
•
•
•
GO Term
GO:0002530 | regulation of systemic arterial blood pressure involved in acute-phase response
Description: Any process that modulates the force with which blood travels through the circulatory system that contributes to the acute phase response. The acute phase response occurs during the early phases of an infection and is marked by changes in the production of plasma proteins such as C-reactive protein.
•
•
•
•
•
GO Term
GO:0002531 | regulation of heart contraction involved in acute-phase response
Description: Any process that modulates the frequency, rate or extent of heart contraction that contributes to the acute phase response. The acute phase response occurs during the early phases of an infection and is marked by changes in the production of plasma proteins such as C-reactive protein.
•
•
•
•
•
GO Term
GO:0002533 | lysosomal enzyme secretion involved in inflammatory response
Description: The regulated release of lysosomal enzymes by a cell as part of an inflammatory response.
•
•
•
•
•
GO Term
GO:0033299 | secretion of lysosomal enzymes
Description: The controlled release of lysosomal enzymes by a cell.
•
•
•
•
•
GO Term
GO:0002535 | platelet activating factor secretion involved in inflammatory response
Description: The regulated release of platelet activating factor by a cell as part of an inflammatory response.
•
•
•
•
•
GO Term
GO:0002536 | respiratory burst involved in inflammatory response
Description: A phase of elevated metabolic activity, during which oxygen consumption increases following a stimulus as part of an inflammatory response; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals, resulting in an increase in their intracellular or extracellular levels.
•
•
•
•
•
GO Term
GO:0002679 | respiratory burst involved in defense response
Description: A phase of elevated metabolic activity, during which oxygen consumption increases made as part of a defense response ; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.
•
•
•
•
•
GO Term
GO:0002537 | nitric oxide production involved in inflammatory response
Description: The synthesis or release of nitric oxide following a stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.
•
•
•
•
•
GO Term
GO:0002538 | arachidonic acid metabolite production involved in inflammatory response
Description: The synthesis or release of products of arachidonic acid metabolism following a stimulus as part of an inflammatory response, resulting in an increase in their intracellular or extracellular levels.
•
•
•
•
•
GO Term
GO:0002539 | prostaglandin production involved in inflammatory response
Description: The synthesis or release of any prostaglandin following a stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.
•
•
•
•
•
GO Term
GO:0002540 | leukotriene production involved in inflammatory response
Description: The synthesis or release of any leukotriene following a stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.
•
•
•
•
•
GO Term
GO:0002541 | activation of plasma proteins involved in acute inflammatory response
Description: Any process activating plasma proteins by proteolysis as part of an acute inflammatory response.
•
•
•
•
•
GO Term
GO:0010954 | positive regulation of protein processing
Description: Any process that increases the rate, frequency or extent of protein maturation by peptide bond cleavage.
•
•
•
•
•
GO Term
GO:0002542 | Factor XII activation
Description: Any process that activates Factor XII (Hageman factor). Factor XII is a protein synthesized by the liver that circulates in an inactive form until it encounters collagen or basement membrane or activated platelets (as occurs at the site of endothelial injury). Factor XII then undergoes a conformational change (becoming factor XIIa), exposing an active serine center that can subsequently cleave protein substrates and activate a variety of mediator systems. Factor XII is a participant in the clotting cascade as well as the kinin cascade.
•
•
•
•
•
GO Term
GO:0070613 | regulation of protein processing
Description: Any process that modulates the frequency, rate or extent of protein processing, any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein.
•
•
•
•
•
GO Term
GO:1903317 | regulation of protein maturation
Description: Any process that modulates the frequency, rate or extent of protein maturation.
•
•
•
•
•
GO Term
GO:1903319 | positive regulation of protein maturation
Description: Any process that activates or increases the frequency, rate or extent of protein maturation.
•
•
•
•
•
GO Term
GO:0030194 | positive regulation of blood coagulation
Description: Any process that activates or increases the frequency, rate or extent of blood coagulation.
•
•
•
•
•
GO Term
GO:0002543 | activation of blood coagulation via clotting cascade
Description: Any process that initiates the clotting cascade of blood coagulation, a cascade of plasma enzymes that is triggered following damage to blood vessels, leading to formation of a clot.
•
•
•
•
•
GO Term
GO:0050820 | positive regulation of coagulation
Description: Any process that activates or increases the frequency, rate or extent of coagulation.
•
•
•
•
•
GO Term
GO:0090303 | positive regulation of wound healing
Description: Any process that increases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.
•
•
•
•
•
GO Term
GO:1900048 | positive regulation of hemostasis
Description: Any process that activates or increases the frequency, rate or extent of hemostasis.
•
•
•
•
•
GO Term
GO:1900046 | regulation of hemostasis
Description: Any process that modulates the frequency, rate or extent of hemostasis.
•
•
•
•
•
GO Term
GO:1903036 | positive regulation of response to wounding
Description: Any process that activates or increases the frequency, rate or extent of response to wounding.
•
•
•
•
•
GO Term
GO:0002545 | chronic inflammatory response to non-antigenic stimulus
Description: A chronic inflammatory response to a non-antigenic stimulus such as heat or physical trauma.
•
•
•
•
•
GO Term
GO:0002546 | negative regulation of tissue kallikrein-kinin cascade
Description: Any process that stops, prevents, or reduces the frequency, rate, or extent of the tissue kallikrein-kinin cascade.
•
•
•
•
•
GO Term
GO:0002547 | positive regulation of tissue kallikrein-kinin cascade
Description: Any process that activates or increases the frequency, rate, or extent of the tissue kallikrein-kinin cascade.
•
•
•
•
•
GO Term
GO:0002548 | monocyte chemotaxis
Description: The movement of a monocyte in response to an external stimulus.
•
•
•
•
•
GO Term
GO:0002549 | negative regulation of plasma kallikrein-kinin cascade
Description: Any process that stops, prevents, or reduces the frequency, rate, or extent of the plasma kallikrein-kinin cascade.
•
•
•
•
•
GO Term
GO:0002550 | positive regulation of plasma kallikrein-kinin cascade
Description: Any process that activates or increases the frequency, rate, or extent of the plasma kallikrein-kinin cascade.
•
•
•
•
•
GO Term
GO:0002551 | mast cell chemotaxis
Description: The movement of a mast cell in response to an external stimulus.
•
•
•
•
•
GO Term
GO:0097531 | mast cell migration
Description: The movement of a mast cell within or between different tissues and organs of the body.
•
•
•
•
•
GO Term
GO:0002552 | serotonin secretion by mast cell
Description: The regulated release of serotonin by a mast cell or group of mast cells.
•
•
•
•
•
GO Term
GO:0043299 | leukocyte degranulation
Description: The regulated exocytosis of secretory granules by a leukocyte.
•
•
•
•
•
GO Term
GO:0002553 | histamine secretion by mast cell
Description: The regulated release of histamine by a mast cell or group of mast cells.
•
•
•
•
•
GO Term
GO:0002554 | serotonin secretion by platelet
Description: The regulated release of serotonin by a platelet or group of platelets.
•
•
•
•
•
GO Term
GO:0002576 | platelet degranulation
Description: The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
•
•
•
•
•
GO Term
GO:0002555 | histamine secretion by platelet
Description: The regulated release of histamine by a platelet or group of platelets.
•
•
•
•
•
GO Term
GO:0002556 | serotonin secretion by basophil
Description: The regulated release of serotonin by a basophil or group of basophils.
•
•
•
•
•
GO Term
GO:0002561 | basophil degranulation
Description: The regulated exocytosis of secretory granules containing preformed mediators such as histamine, serotonin, and neutral proteases by a basophil.
•
•
•
•
•
GO Term
GO:0002560 | basophil mediated immunity
Description: Any process involved in the carrying out of an immune response by a basophil.
•
•
•
•
•
GO Term
GO:0002557 | histamine secretion by basophil
Description: The regulated release of histamine by a basophil or group of basophils.
•
•
•
•
•
GO Term
GO:0002558 | type I hypersensitivity mediated by mast cells
Description: An inflammatory response driven by antigen recognition by antibodies bound to Fc receptors on mast cells, occurring within minutes after exposure of a sensitized individual to the antigen, and leading to the release of a variety of inflammatory mediators such as histamines.
•
•
•
•
•
GO Term
GO:0002559 | type I hypersensitivity mediated by basophils
Description: An inflammatory response driven by antigen recognition by antibodies bound to Fc receptors basophils, occurring within minutes after exposure of a sensitized individual to the antigen, and leading to the release of a variety of inflammatory mediators such as histamines.
•
•
•
•
•
GO Term
GO:0002563 | somatic diversification of immune receptors via alternate splicing
Description: The process in which immune receptor genes are diversified through alternate splicing.
•
•
•
•
•
GO Term
GO:0002564 | alternate splicing of immunoglobulin genes
Description: The generation of alternate transcripts of immunoglobulin genes through alternate splicing of exons.
•
•
•
•
•
GO Term
GO:0002567 | somatic diversification of FREP-based immune receptors
Description: The process that results in the generation of sequence diversity of the FREP-based immune receptors of snails.
•
•
•
•
•
GO Term
GO:0002568 | somatic diversification of T cell receptor genes
Description: The somatic process that results in the generation of sequence diversity of T cell receptor genes.
•
•
•
•
•
GO Term
GO:0002569 | somatic diversification of immune receptors by N region addition
Description: The addition of variable numbers of random nucleotides by terminal deoxytransferase in the N regions of heavy chain immunoglobulin and T cell receptor genes. N regions are found at the V-D, D-D, V-J, and D-J recombinational junctions, depending on the immune receptor gene.
•
•
•
•
•
GO Term
GO:0002570 | somatic diversification of immunoglobulin genes by N region addition
Description: The addition of variable numbers of random nucleotides by terminal deoxytransferase in the N regions of heavy chain immunoglobulin genes. N regions are found at the V-D and D-J recombinational junctions.
•
•
•
•
•
GO Term
GO:0002571 | somatic diversification of T cell receptor genes by N region addition
Description: The addition of variable numbers of random nucleotides by terminal deoxytransferase in the N regions of T cell receptor genes. N regions are found at the V-D, D-D, V-J, and D-J recombinational junctions, depending on the T cell receptor gene.
•
•
•
•
•
GO Term
GO:0002681 | somatic recombination of T cell receptor gene segments
Description: The process in which T cell receptor genes are formed through recombination of the germline genetic elements, also known as T cell receptor gene segments.
•
•
•
•
•
GO Term
GO:0002572 | pro-T cell differentiation
Description: The process in which a precursor cell type acquires the specialized features of a pro-T cell. Pro-T cells are the earliest stage of the T cell lineage but are not fully committed.
•
•
•
•
•
GO Term
GO:0002574 | thrombocyte differentiation
Description: The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a thrombocyte, a nucleated cell found in all vertebrates but mammals involved in hemostasis.
•
•
•
•
•
GO Term
GO:0002575 | basophil chemotaxis
Description: The movement of a basophil in response to an external stimulus.
•
•
•
•
•
USDA
InterMine logo
The Legume Information System (LIS) is a research project of the USDA-ARS:Corn Insects and Crop Genetics Research in Ames, IA.
LegumeMine || ArachisMine | CicerMine | GlycineMine | LensMine | LupinusMine | PhaseolusMine | VignaMine | MedicagoMine
InterMine © 2002 - 2022 Department of Genetics, University of Cambridge, Downing Street, Cambridge CB2 3EH, United Kingdom